Les Ulis, France

Lionel Trottet



 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lionel Trottet

Introduction

Lionel Trottet is a notable inventor based in Les Ulis, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of three patents to his name, Trottet's work focuses on compounds that have important applications in medicine.

Latest Patents

Trottet's latest patents include the development of substituted triazole compounds, which are described by the formula (I) and their pharmaceutically acceptable salts. These compounds are particularly relevant for modulating stearoyl-CoA desaturase (SCD) activity. His inventions also encompass 1,2,3-triazole derivatives that serve as inhibitors of SCD, showcasing his commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Throughout his career, Lionel Trottet has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline LLC and Glaxo Group Limited. His experience in these organizations has undoubtedly contributed to his expertise and success as an inventor.

Collaborations

Trottet has collaborated with several professionals in his field, including Anne Marie Jeanne Bouillot and Alain Laroze. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Lionel Trottet's contributions to pharmaceutical innovation through his patents reflect his dedication to improving medical treatments. His work with triazole compounds and collaborations with industry professionals highlight his significant role in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…